SESSION ONE: OPAT - WHERE ARE WE NOW?
The video consists of the following presentations:
Watch Video
Welcome & introduction
Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde
BSAC OPAT Strategy & Key achievements in 2021/22
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust
Setting the standard for OPAT in Scotland
Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde
NHS England – taking a strategic approach to OPAT
Conor Jamieson, Regional Antimicrobial Stewardship Lead Midlands Region, NHS England
OPAT developments in Paediatrics
Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital
Panel discussion: How can we share successes to work better together?
All speakers
SESSION TWO: INNOVATIONS IN OPAT/ COPAT DRUG DELIVERY
The video consists of the following presentations:
Watch Video
Aciclovir in elastomerics - It is now possible?
Fekade Sime, NHMRC Emerging Leadership Fellow, University of Queensland Centre for Clinical Research
Probenecid and beta lactams in OPAT/CoPAT - New Zealand experience
Richard Everts, Infectious Diseases Specialist, Nelson Bays Primary Health, New Zealand
One size does not fit all in COPAT - practical considerations
Lee Stewart, Antimicrobials Pharmacist, South Glasgow Hospitals
OPAT vs COPAT outcomes
Peter McKee, Antimicrobial Pharmacist, Southern Health and Social Care Trust, Craigavon Area Hospital
Q&A
SESSION FOUR: CLINICAL CASE STUDIES - INVITED PAPERS FROM OPAT REGIONAL WORKSHOPS & ABSTRACTS
The video consists of the following presentations:
Watch Video
Life prolongation at what cost…..An OPAT story
Carolyn Hemsley, Infectious Diseases and Microbiology Consultant, Guy’s & St Thomas’ NHS Foundation
OPAT and the vulnerable adult
Meghan Perry, Consultant Physician and Honorary Senior Clinical Lecturer in Infectious Diseases and General Internal Medicine, Western General Hospital, Edinburgh
Use of Charlson Comorbidity Index to Predict Risk of Readmission for OPAT Patients: A Quality Improvement Project
Ryan Stubbs, Medical Student, University of Manchester
Q&A
SESSION SIX: INTERNATIONAL OPAT
The video consists of the following presentations:
Watch Video
Overview of OPAT within Europe
Caroline Emilie, Université de Lorraine, France
Overview of OPAT within USA
Monica Mahoney, Clinical Pharmacy Specialist, Infectious Diseases Outpatient ID/OPAT Clinics, Beth Israel Deaconess Medical Center, Boston, USA
Q&A
Closing remarks
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust
FREE PAPER: The Blackpool OPAT model: An acute-primary care-CCG partnership developed community/home intravenous therapy service for residents of the Flyde Coast
Dr Achyut Guleri
Download VideoDownload Slides
Drug stability – an evidence review and development of a national methodology for stability testing of agents and devices
Mr Tim Hills
Download VideoDownload Slides
Welcome & Overview – The UK OPAT Initiative: Then, now & in the future and overview of the 2013 audit
Mark Gilchrist, Consultant Pharmacist, Imperial college Healthcare NHS Trust & Dr Andrew Seaton, Consultant Physician, Gartnavel General Hospital
Download VideoDownload Slides
OPAT & Paediatric OPAT standards and practical implications of the hospital and community
Dr Sanjay Patel, Consultant Paediatrician, Southampton University Hospital NHS Foundation Trust & Dr Ann Chapman, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield
Download VideoDownload Slides
Recording OPAT treatment episodes and outcomes – Review of the UK Patient Management System and UK Outcomes Registry
Mark Gilchrist, Consultant Pharmacist, Imperial college Healthcare NHS Trust
Download VideoDownload Slides
Funding Acquisition and business case development
Dr Amandip Sahota, ST7 & Dr Susan Alleyne, Consultant Microbiologist, University Hospital of Leicester NHS Foundation Trust
Download VideoDownload Slides
Hall 5 – Key Considerations – Choice of antimicrobial agents and managing the IV to oral switch
Dr Andrew Seaton, Consultant Physician, Gartnavel General Hospital
Download VideoDownload Slides
Funding Acquisition and business case development – A Scottish perspective
Dr Claire Mackintosh, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh
Download VideoDownload Slides
Commissioning OPAT services – Balancing the Elements
Sharon Rourke, Senior Commissions Manager, Acute and Service Redesign, NHS Blackpool Clinical Commissioning Group
Download VideoDownload Slides
Hall 5 – Device choices for OPAT – Stability data and patient safety
Tim Hills, Antimicrobial Pharmacist, University Hospitals of Nottingham NHS Trust
Download VideoDownload Slides
The District General Hospital Experience
Professor Sajjad Mirza, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield
Download VideoDownload Slides
OPAT in the Teaching hospital / Tertiary centre
Dr Ann Chapman, Consultant in Infectious Diseases, Royal Hallamshire Hospital, Sheffield
Download VideoDownload Slides
Successful fulfilment of an OPAT service through a private provider
Dr Susan Clarke, Clinical Lead for National OPAT Programme Ireland, St James’ Hospital, Dublin
Download VideoDownload Slides
Providing the best outcomes for patients – Closing remarks
Dr Frances Sanderson, Consultant in Infectious Diseases, Imperial College Healthcare NHS Trust
Download Video